We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PTAB Upholds Grunenthal’s Patent Challenge for Pain Treatment
PTAB Upholds Grunenthal’s Patent Challenge for Pain Treatment
The U.S. Patent Trial and Review Board has invalidated an Antecip Bioventures patent for neridronic acid as a treatment for complex regional pain syndrome (CRPS).
